RxDoctor Payments Data

Christine Slocum

Psychiatric/Mental Health · Poughkeepsie, NYNPI 1063573053

Payments from drug & device makers

$1,850in general payments, 2019–2025

Across 95 payments — averaging $19.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$678
  • Johnson & Johnson$226
  • Teva Pharmaceuticals USA, Inc.$145
  • Alkermes, Inc.$132
  • Corium, LLC$110
  • Otsuka America Pharmaceutical, Inc.$106
  • plus $453 from 8 others

What the payments were for

  • Food & beverage$1,72393%
  • Education$1277%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,850 in reported general payments places this provider in the 75th percentile of 2,385 psychiatric/mental health providers in New York.

See all psychiatric/mental health providers in New York

Medicare billing

Part B allowed, 2024
$54,541
Medicare patients
92
Services billed
482

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
IngrezzaValbenazine Tosylate44$366,677
VraylarCariprazine Hcl95$148,263
RexultiBrexpiprazole58$82,355
Invega SustennaPaliperidone Palmitate24$67,573
Abilify MaintenaAripiprazole24$67,188
CaplytaLumateperone Tosylate23$37,335
Lurasidone Hcl63$14,598
TrintellixVortioxetine Hydrobromide30$14,376
Bupropion XlBupropion Hcl128$8,571
Aripiprazole71$8,234
Quetiapine Fumarate157$6,603
Clozapine63$4,522
BelsomraSuvorexant12$4,402
Clonazepam281$4,371
Paliperidone ErPaliperidone30$4,279

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Neurocrine Biosciences, Inc.Ingrezza$100$366,67744 claims
Otsuka America Pharmaceutical, Inc.Rexulti, Abilify Maintena$106$149,54482 claims
AbbVieVraylar$678$148,26395 claims
Johnson & JohnsonInvega Sustenna$226$67,57324 claims
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta$89$37,33523 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$38$14,37630 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 2,385 psychiatric/mental health providers in New York.

Other psychiatric/mental health in Poughkeepsie

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →